Published in Obesity and Diabetes Week, January 17th, 2005
Rosiglitazone is the active pharmaceutical ingredient used in the prescription drugs Avandia (Rosiglitazone maleate) and Avandamet (Metformin HCl/Rosiglitazone maleate) to treat type II diabetes. In 2003, GlaxoSmithKline (NYSE: GSK - News) reported nearly $1.5 billion in global Avandia and Avandamet sales.
Provisional patents allow a filer to establish a priority filing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week